BREXIT Guidance for the pharmaceutical industry – what have we been told so far?
A multitude of BREXIT guidance has been published by the UK government via the MHRA, and by the European Union via the EMA. To be helpful, we’ve collated links to some of the documents [...]
MHRA – Guidance on QPPV including PSMF if the UK leaves the EU without a deal
The MHRA has today Published guidance on the pharmacovigilance system requirements after the UK leaves the EU. Click here to find out more: Medicines and Healthcare products Regulatory Agency New [...]
Panacea Celebrate International Women’s Day 2019
Here at Panacea we’ve been celebrating International Women’s Day, the global day celebrating the social, economic, cultural and political achievements of women. The day also marks a [...]
Well done to the Isle of Man Young Enterprise students – especially the Gravity team
It was fantastic to see the efforts of the island’s students come together at the final exhibition of the Junior Achievement Isle of Man Young Enterprise programme this week. Students from [...]
Brexit: Brief guidance for marketing authorisation holders…in the event of a No Deal
As it stands the UK remains on course to leave the EU on 29 March 2019. That is of course unless a number of other scenarios don’t play out, including a delay. At Panacea, we’ve kept track of the [...]
PANACEA – Dress in Yellow for Sexual Abuse and Sexual Violence Awareness Week
This week we are raising money for Victim Support Isle of Man and all wearing yellow for their Dress in Yellow Day, as part of Sexual Abuse and Sexual Violence Awareness Week (4th-10th Feb). It [...]
Panacea’s Christmas Jumper Day effort – for Save the Children
Today is Save the Children’s #ChristmasJumperDay Save the Children provide vital help to the children who really need it, the money donated could help in supplying lifesaving drugs, reading [...]
EMA – New GVP chapter IV on specific considerations for the paediatric population
Last month the EMA published the new good pharmacovigilance practice (GVP) chapter IV. This chapter has specific considerations for the paediatric population addressing the needs and challenges [...]
